{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:43Z","timestamp":1793296063905,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Postdoctoral Fellowship Program of CPSF","award":["GZC20251840"],"award-info":[{"award-number":["GZC20251840"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370110"],"award-info":[{"award-number":["32370110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gansu Province Science and Technology Major Project","award":["24ZDWA005"],"award-info":[{"award-number":["24ZDWA005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12602-026-11048-0","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:10:27Z","timestamp":1778922627000},"page":"8810-8830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti\u2013PD-1 Immunotherapy Efficacy"],"prefix":"10.1007","volume":"18","author":[{"given":"Wei","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Sayed","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"1","key":"11048_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan XY (2024) Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct Target Ther 9(1):175. https:\/\/doi.org\/10.1038\/s41392-024-01856-7","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"11048_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J (2023) Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol 20(7):429\u2013452. https:\/\/doi.org\/10.1038\/s41571-023-00766-x","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"11048_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.apsb.2023.09.007","volume":"14","author":"Y Lee","year":"2024","unstructured":"Lee Y, Song S, Yang S, Kim J, Moon Y, Shim N et al (2024) Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy. Acta Pharm Sin B 14(3):1428\u20131440. https:\/\/doi.org\/10.1016\/j.apsb.2023.09.007","journal-title":"Acta Pharm Sin B"},{"key":"11048_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","author":"A Wolchok","year":"2018","unstructured":"Wolchok A (2018) Cancer immunotherapy using checkpoint blockade. Science. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science"},{"issue":"16","key":"11048_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD et al (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381(16):1535\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"},{"issue":"2","key":"11048_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1470-2045(20)30641-0","volume":"22","author":"L Paz-Ares","year":"2021","unstructured":"Paz-Ares L, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J et al (2021) First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): An international, randomised, open-label, phase 3 trial. Lancet Oncol 22(2):198\u2013211. https:\/\/doi.org\/10.1016\/S1470-2045(20)30641-0","journal-title":"Lancet Oncol"},{"key":"11048_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40364-020-00212-5","volume":"8","author":"JY Sun","year":"2020","unstructured":"Sun JY, Zhang D, Wu S, Xu M, Zhou X, Lu XJ et al (2020) Resistance to PD-1\/PD-L1 blockade cancer immunotherapy: Mechanisms, predictive factors, and future perspectives. Biomark Res 8:35. https:\/\/doi.org\/10.1186\/s40364-020-00212-5","journal-title":"Biomark Res"},{"issue":"8","key":"11048_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C (2020) Immune checkpoint signaling and cancer immunotherapy. Cell Res 30(8):660\u2013669. https:\/\/doi.org\/10.1038\/s41422-020-0343-4","journal-title":"Cell Res"},{"key":"11048_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.166773","volume":"904","author":"Y Wu","year":"2023","unstructured":"Wu Y, Peng L, Feng P, Han R, Khan A, Kulshreshtha S et al (2023) Gut microbes consume host energy and reciprocally provide beneficial factors to sustain a symbiotic relationship with the host. Sci Total Environ 904:166773. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.166773","journal-title":"Sci Total Environ"},{"issue":"4","key":"11048_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33(4):570\u2013580. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.015","journal-title":"Cancer Cell"},{"issue":"2","key":"11048_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","volume":"165","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L, Ayyoub M, Routy B, Kroemer G (2016) Microbiome and anticancer immunosurveillance. Cell 165(2):276\u2013287. https:\/\/doi.org\/10.1016\/j.cell.2016.03.001","journal-title":"Cell"},{"issue":"11","key":"11048_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong SH, Yu J (2019) Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol 16(11):690\u2013704. https:\/\/doi.org\/10.1038\/s41575-019-0209-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11048_CR13","doi-asserted-by":"publisher","unstructured":"Fukugaiti MH, Ignacio A, Fernandes MR, Ribeiro U Junior, Nakano V, Avila-Campos MJ (2015) High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients. Braz J Microbiol 46(4):1135\u20131140. https:\/\/doi.org\/10.1590\/S1517-838246420140665","DOI":"10.1590\/S1517-838246420140665"},{"issue":"8","key":"11048_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv147","volume":"107","author":"JJ Goedert","year":"2015","unstructured":"Goedert JJ, Jones G, Hua X, Xu X, Yu GQ, Flores R et al (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 107(8):djv147. https:\/\/doi.org\/10.1093\/jnci\/djv147","journal-title":"J Natl Cancer Inst"},{"issue":"6371","key":"11048_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91\u201397. https:\/\/doi.org\/10.1126\/science.aan3706","journal-title":"Science"},{"issue":"6371","key":"11048_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104\u2013108. https:\/\/doi.org\/10.1126\/science.aao3290","journal-title":"Science"},{"issue":"1","key":"11048_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0574-4","volume":"7","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF (2019) Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer 7(1):108. https:\/\/doi.org\/10.1186\/s40425-019-0574-4","journal-title":"J Immunother Cancer"},{"issue":"3","key":"11048_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10549-019-05407-5","volume":"178","author":"J Chen","year":"2019","unstructured":"Chen J, Douglass J, Prasath V, Neace M, Atrchian S, Manjili MH et al (2019) The microbiome and breast cancer: a review. Breast Cancer Res Treat 178(3):493\u2013496. https:\/\/doi.org\/10.1007\/s10549-019-05407-5","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"11048_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G (2022) Targeting the gut microbiota for cancer therapy. Nat Rev Cancer 22(12):703\u2013722. https:\/\/doi.org\/10.1038\/s41568-022-00513-x","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11048_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0672-4","volume":"11","author":"BA Peters","year":"2019","unstructured":"Peters BA, Wilson M, Moran U, Pavlick A, Izsak A, Wechter T et al (2019) Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. Genome Med 11(1):61. https:\/\/doi.org\/10.1186\/s13073-019-0672-4","journal-title":"Genome Med"},{"issue":"1","key":"11048_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-021-00499-1","volume":"19","author":"DA Schupack","year":"2022","unstructured":"Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC (2022) The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol 19(1):7\u201325. https:\/\/doi.org\/10.1038\/s41575-021-00499-1","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6264","key":"11048_CR22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350(6264):1084\u20131089. https:\/\/doi.org\/10.1126\/science.aac4255","journal-title":"Science"},{"issue":"7741","key":"11048_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y et al (2019) A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565(7741):600\u2013605. https:\/\/doi.org\/10.1038\/s41586-019-0878-z","journal-title":"Nature"},{"issue":"10","key":"11048_CR24","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41416-021-01562-z","volume":"126","author":"X Liu","year":"2022","unstructured":"Liu X, Jin G, Tang Q, Huang S, Zhang Y, Sun Y et al (2022) Early life Lactobacillus rhamnosus GG colonisation inhibits intestinal tumour formation. Br J Cancer 126(10):1421\u20131431. https:\/\/doi.org\/10.1038\/s41416-021-01562-z","journal-title":"Br J Cancer"},{"issue":"1","key":"11048_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1774298","volume":"9","author":"R Daillere","year":"2020","unstructured":"Daillere R, Derosa L, Bonvalet M, Segata N, Routy B, Gariboldi M et al (2020) Trial watch: the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy. Oncoimmunology 9(1):1774298. https:\/\/doi.org\/10.1080\/2162402X.2020.1774298","journal-title":"Oncoimmunology"},{"key":"11048_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092207","author":"M Ozen","year":"2023","unstructured":"Ozen M, Piloquet H, Schaubeck M (2023) Limosilactobacillus fermentum CECT5716: clinical potential of a probiotic strain isolated from human milk. Nutrients. https:\/\/doi.org\/10.3390\/nu15092207","journal-title":"Nutrients"},{"issue":"1","key":"11048_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897211","volume":"13","author":"Y Wu","year":"2021","unstructured":"Wu Y, Ye Z, Feng P, Li R, Chen X, Tian X et al (2021) Limosilactobacillus fermentum JL-3 isolated from \u201cJiangshui\u201d ameliorates hyperuricemia by degrading uric acid. Gut Microbes 13(1):1\u201318. https:\/\/doi.org\/10.1080\/19490976.2021.1897211","journal-title":"Gut Microbes"},{"issue":"10","key":"11048_CR28","doi-asserted-by":"publisher","first-page":"ARTN 105198","DOI":"10.1016\/j.isci.2022.105198","volume":"25","author":"S Zhao","year":"2022","unstructured":"Zhao S, Feng PY, Hu XG, Cao WJ, Liu P, Han HW et al (2022) Probiotic GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid. Iscience. 25(10):ARTN 105198. https:\/\/doi.org\/10.1016\/j.isci.2022.105198","journal-title":"Iscience."},{"key":"11048_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113216","volume":"231","author":"R Han","year":"2022","unstructured":"Han R, Khan A, Ling Z, Wu Y, Feng P, Zhou T et al (2022) Feed-additive Limosilactobacillus fermentum GR-3 reduces arsenic accumulation in Procambarus clarkii. Ecotoxicol Environ Saf 231:113216. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113216","journal-title":"Ecotoxicol Environ Saf"},{"issue":"31","key":"11048_CR30","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1021\/acs.jafc.0c02797","volume":"68","author":"L Hao","year":"2020","unstructured":"Hao L, Gao X, Zhou T, Cao J, Sun Y, Dang Y et al (2020) Angiotensin I-converting enzyme (ACE) inhibitory and antioxidant activity of umami peptides after in vitro gastrointestinal digestion. J Agric Food Chem 68(31):8232\u20138241. https:\/\/doi.org\/10.1021\/acs.jafc.0c02797","journal-title":"J Agric Food Chem"},{"key":"11048_CR31","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.scitotenv.2018.11.063","volume":"653","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhang Q, Pang Y, Song X, Zhou N, Wang J et al (2019) The protective effects of melatonin on oxidative damage and the immune system of the Chinese mitten crab (Eriocheir sinensis) exposed to deltamethrin. Sci Total Environ 653:1426\u20131434. https:\/\/doi.org\/10.1016\/j.scitotenv.2018.11.063","journal-title":"Sci Total Environ"},{"key":"11048_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.lwt.2015.10.045","volume":"66","author":"F Manini","year":"2016","unstructured":"Manini F, Casiraghi MC, Poutanen K, Brasca M, Erba D, Plumed-Ferrer C (2016) Characterization of lactic acid bacteria isolated from wheat bran sourdough. LWT - Food Sci Technol 66:275\u2013283. https:\/\/doi.org\/10.1016\/j.lwt.2015.10.045","journal-title":"LWT - Food Sci Technol"},{"key":"11048_CR33","doi-asserted-by":"publisher","unstructured":"de Oliveira Coelho B, Fiorda-Mello F, de Melo Pereira GV, Thomaz-Soccol V, Rakshit SK, de Carvalho JC et al (2019) In vitro probiotic properties and DNA protection activity of yeast and lactic acid bacteria isolated from a honey-based kefir beverage. Foods. https:\/\/doi.org\/10.3390\/foods8100485","DOI":"10.3390\/foods8100485"},{"key":"11048_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.foodcont.2013.09.055","volume":"37","author":"S Pieniz","year":"2014","unstructured":"Pieniz S, Andreazza R, Anghinoni T, Camargo F, Brandelli A (2014) Probiotic potential, antimicrobial and antioxidant activities of Enterococcus durans strain LAB18s. Food Control 37:251\u2013256. https:\/\/doi.org\/10.1016\/j.foodcont.2013.09.055","journal-title":"Food Control"},{"key":"11048_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004874","author":"G Deng","year":"2022","unstructured":"Deng G, Zhou L, Wang B, Sun X, Zhang Q, Chen H et al (2022) Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-004874","journal-title":"J Immunother Cancer"},{"issue":"9","key":"11048_CR36","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH et al (2023) Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell 186(9):1846\u201362 e26. https:\/\/doi.org\/10.1016\/j.cell.2023.03.011","journal-title":"Cell"},{"issue":"9","key":"11048_CR37","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1136\/gutjnl-2023-330835","volume":"73","author":"ACY Su","year":"2024","unstructured":"Su ACY, Ding X, Lau HCH, Kang X, Li Q, Wang XL et al (2024) suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase. Gut 73(9):1478\u20131488. https:\/\/doi.org\/10.1136\/gutjnl-2023-330835","journal-title":"Gut"},{"issue":"1","key":"11048_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41538-024-00307-5","volume":"8","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wu J, Khan A, Hu T, Wang Y, Salama E-S et al (2024) A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. npj Sci Food 8(1):61. https:\/\/doi.org\/10.1038\/s41538-024-00307-5","journal-title":"npj Sci Food"},{"issue":"19","key":"11048_CR39","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1039\/d2fo01747d","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wang Y, Wang J, Lv M, Zhou C, Jia L et al (2022) Lactobacillus kefiranofaciens ZW18 from Kefir enhances the anti-tumor effect of anti-Programmed Cell Death 1 (PD-1) immunotherapy by modulating the gut microbiota. Food Funct 13(19):10023\u201310033. https:\/\/doi.org\/10.1039\/d2fo01747d","journal-title":"Food Funct"},{"issue":"6","key":"11048_CR40","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001552","volume":"71","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang HJ, Chen R, Lee WH, Zhao HB (2022) 16S rDNA analysis of osteoporotic rats treated with Osteoking. J Med Microbiol 71(6):001552. https:\/\/doi.org\/10.1099\/jmm.0.001552","journal-title":"J Med Microbiol"},{"issue":"7","key":"11048_CR41","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1128\/AEM.01843-08","volume":"75","author":"K Matsuda","year":"2009","unstructured":"Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K (2009) Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75(7):1961\u20131969. https:\/\/doi.org\/10.1128\/AEM.01843-08","journal-title":"Appl Environ Microbiol"},{"key":"11048_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121709","volume":"324","author":"H Tang","year":"2023","unstructured":"Tang H, Zhou T, Jin W, Zong S, Mamtimin T, Salama ES et al (2023) Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice. Life Sci 324:121709. https:\/\/doi.org\/10.1016\/j.lfs.2023.121709","journal-title":"Life Sci"},{"issue":"1","key":"11048_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2307542","volume":"16","author":"X Yu","year":"2024","unstructured":"Yu X, Ou J, Wang L, Li Z, Ren Y, Xie L et al (2024) Gut microbiota modulate CD8(+) T cell immunity in gastric cancer through butyrate\/GPR109A\/HOPX. Gut Microbes 16(1):2307542. https:\/\/doi.org\/10.1080\/19490976.2024.2307542","journal-title":"Gut Microbes"},{"issue":"5","key":"11048_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"issue":"2","key":"11048_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S et al (2022) Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med 28(2):315\u2013324. https:\/\/doi.org\/10.1038\/s41591-021-01655-5","journal-title":"Nat Med"},{"issue":"44","key":"11048_CR46","doi-asserted-by":"publisher","first-page":"27509","DOI":"10.1073\/pnas.1921223117","volume":"117","author":"S Sun","year":"2020","unstructured":"Sun S, Luo L, Liang W, Yin Q, Guo J, Rush AM et al (2020) Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade. Proc Natl Acad Sci U S A 117(44):27509\u201327515. https:\/\/doi.org\/10.1073\/pnas.1921223117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"11048_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","volume":"29","author":"DF Evans","year":"1988","unstructured":"Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD (1988) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29(8):1035\u20131041. https:\/\/doi.org\/10.1136\/gut.29.8.1035","journal-title":"Gut"},{"issue":"5","key":"11048_CR48","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1021\/mp100144v","volume":"7","author":"E Soderlind","year":"2010","unstructured":"Soderlind E, Karlsson E, Carlsson A, Kong R, Lenz A, Lindborg S et al (2010) Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids. Mol Pharm 7(5):1498\u20131507. https:\/\/doi.org\/10.1021\/mp100144v","journal-title":"Mol Pharm"},{"issue":"5","key":"11048_CR49","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s12602-021-09775-7","volume":"13","author":"JJ Ahire","year":"2021","unstructured":"Ahire JJ, Jakkamsetty C, Kashikar MS, Lakshmi SG, Madempudi RS (2021) In vitro evaluation of probiotic properties of Lactobacillus plantarum UBLP40 isolated from traditional indigenous fermented food. Probiotics Antimicrob Proteins 13(5):1413\u20131424. https:\/\/doi.org\/10.1007\/s12602-021-09775-7","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"20","key":"11048_CR50","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1128\/AEM.00886-07","volume":"73","author":"B Sanchez","year":"2007","unstructured":"Sanchez B, Champomier-Verges MC, Collado MC, Anglade P, Baraige F, Sanz Y et al (2007) Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum. Appl Environ Microbiol 73(20):6450\u20136459. https:\/\/doi.org\/10.1128\/AEM.00886-07","journal-title":"Appl Environ Microbiol"},{"key":"11048_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jconrel.2016.04.009","volume":"230","author":"R Li","year":"2016","unstructured":"Li R, Zhang Y, Polk DB, Tomasula PM, Yan F, Liu L (2016) Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system. J Control Release 230:79\u201387. https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.009","journal-title":"J Control Release"},{"key":"11048_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1163662","author":"Y Hu","year":"2023","unstructured":"Hu Y, Zhao Y, Jia X, Liu D, Huang X, Wang C et al (2023) Lactic acid bacteria with a strong antioxidant function isolated from \u201cJiangshui,\u201d pickles, and feces. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1163662","journal-title":"Front Microbiol"},{"key":"11048_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1801944","author":"T Feng","year":"2020","unstructured":"Feng T, Wang J (2020) Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2020.1801944","journal-title":"Gut Microbes"},{"issue":"2","key":"11048_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1152\/physrev.00024.2002","volume":"83","author":"M Mareel","year":"2003","unstructured":"Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83(2):337\u2013376. https:\/\/doi.org\/10.1152\/physrev.00024.2002","journal-title":"Physiol Rev"},{"key":"11048_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110159","volume":"127","author":"Y Yue","year":"2020","unstructured":"Yue Y, Ye K, Lu J, Wang X, Zhang S, Liu L et al (2020) Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment. Biomed Pharmacother 127:110159. https:\/\/doi.org\/10.1016\/j.biopha.2020.110159","journal-title":"Biomed Pharmacother"},{"key":"11048_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153563","author":"A Aghamajidi","year":"2022","unstructured":"Aghamajidi A, Maleki Vareki S (2022) The effect of the gut microbiota on systemic and anti-tumor immunity and response to systemic therapy against cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14153563","journal-title":"Cancers (Basel)"},{"issue":"6371","key":"11048_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236","journal-title":"Science"},{"issue":"11","key":"11048_CR58","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/aje\/kwu357","volume":"181","author":"A Karahalios","year":"2015","unstructured":"Karahalios A, English DR, Simpson JA (2015) Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol 181(11):832\u2013845. https:\/\/doi.org\/10.1093\/aje\/kwu357","journal-title":"Am J Epidemiol"},{"issue":"16","key":"11048_CR59","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","volume":"381","author":"J Larkin","year":"2019","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD et al (2019) Five-year survival with combined Nivolumab and Ipilimumab in advanced melanoma. N Engl J Med 381(16):1535\u20131546. https:\/\/doi.org\/10.1056\/NEJMoa1910836","journal-title":"N Engl J Med"},{"issue":"6","key":"11048_CR60","first-page":"2719","volume":"36","author":"M Kassayova","year":"2016","unstructured":"Kassayova M, Bobrov N, Strojny L, Orendas P, Demeckova V, Jendzelovsky R et al (2016) Anticancer and immunomodulatory effects of lactobacillus plantarum LS\/07, inulin and melatonin in NMU-induced rat model of breast cancer. Anticancer Res 36(6):2719\u20132728","journal-title":"Anticancer Res"},{"issue":"26","key":"11048_CR61","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"WN Fong","year":"2020","unstructured":"Fong WN, Li Q, Yu J (2020) Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene 39(26):4925\u20134943. https:\/\/doi.org\/10.1038\/s41388-020-1341-1","journal-title":"Oncogene"},{"issue":"6","key":"11048_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19(6):369\u2013382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"11048_CR63","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu M, Pautz S, Kohl V, Singh R, Romero R, Lucas S et al (2019) The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun 10(1):760. https:\/\/doi.org\/10.1038\/s41467-019-08711-2","journal-title":"Nat Commun"},{"issue":"6","key":"11048_CR64","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C et al (2018) Successful Anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12. Immunity 49(6):1148\u201361 e7. https:\/\/doi.org\/10.1016\/j.immuni.2018.09.024","journal-title":"Immunity"},{"issue":"6494","key":"11048_CR65","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT et al (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494):973\u2013980. https:\/\/doi.org\/10.1126\/science.aay9189","journal-title":"Science"},{"key":"11048_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R (2021) The microbiome and human cancer. Science. https:\/\/doi.org\/10.1126\/science.abc4552","journal-title":"Science"},{"issue":"1","key":"11048_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08211-w","volume":"17","author":"J Jia","year":"2025","unstructured":"Jia J, Gao W, Wang C, Liu L, Li Y, Sun Z et al (2025) Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy. Cell Death Dis 17(1):62. https:\/\/doi.org\/10.1038\/s41419-025-08211-w","journal-title":"Cell Death Dis"},{"issue":"4","key":"11048_CR68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A et al (2018) The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov 8(4):403\u2013416. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1134","journal-title":"Cancer Discov"},{"key":"11048_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9537","author":"JH Zheng","year":"2017","unstructured":"Zheng JH, Nguyen VH, Jiang SN, Park SH, Tan W, Hong SH et al (2017) Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aak9537","journal-title":"Sci Transl Med"},{"issue":"7","key":"11048_CR70","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T (2019) Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med 25(7):1057\u20131063. https:\/\/doi.org\/10.1038\/s41591-019-0498-z","journal-title":"Nat Med"},{"key":"11048_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01050","volume":"10","author":"WD Ma","year":"2019","unstructured":"Ma WD, Mao QX, Xia WJ, Dong GC, Yu CH, Jiang F (2019) Gut microbiota shapes the efficiency of cancer therapy. Front Microbiol 10:ARTN 1050. https:\/\/doi.org\/10.3389\/fmicb.2019.01050","journal-title":"Front Microbiol"},{"key":"11048_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2020.109721","volume":"137","author":"B Cruz","year":"2020","unstructured":"Cruz B, Conceicao LLD, Mendes TAO, Ferreira C, Goncalves RV, Peluzio M (2020) Use of the synbiotic VSL#3 and yacon-based concentrate attenuates intestinal damage and reduces the abundance of Candidatus Saccharimonas in a colitis-associated carcinogenesis model. Food Res Int 137:109721. https:\/\/doi.org\/10.1016\/j.foodres.2020.109721","journal-title":"Food Res Int"},{"issue":"4","key":"11048_CR73","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.12760","volume":"151","author":"JM Larsen","year":"2017","unstructured":"Larsen JM (2017) The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology 151(4):363\u2013374. https:\/\/doi.org\/10.1111\/imm.12760","journal-title":"Immunology"},{"key":"11048_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772532","volume":"12","author":"G Gao","year":"2021","unstructured":"Gao G, Ma T, Zhang T, Jin H, Li Y, Kwok LY et al (2021) Adjunctive probiotic Lactobacillus rhamnosus Probio-M9 administration enhances the effect of anti-PD-1 antitumor therapy via restoring antibiotic-disrupted gut microbiota. Front Immunol 12:772532. https:\/\/doi.org\/10.3389\/fimmu.2021.772532","journal-title":"Front Immunol"},{"issue":"12","key":"11048_CR75","doi-asserted-by":"publisher","first-page":"909","DOI":"10.5152\/tjg.2024.23683","volume":"35","author":"S Xu","year":"2024","unstructured":"Xu S, Kong J, Dai Y, Li H (2024) Prevotellaceae modulates colorectal cancer immune microenvironment to assist anti-PD-L1 immunotherapy. Turk J Gastroenterol 35(12):909\u2013921. https:\/\/doi.org\/10.5152\/tjg.2024.23683","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"11048_CR76","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"DP Zheng","year":"2020","unstructured":"Zheng DP, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"issue":"2","key":"11048_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem A, Makhlouf C, Binger KJ, de Souza DP, Tull D, Hochheiser K et al (2019) Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8(+) T cells. Immunity 51(2):285\u201397 e5. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.002","journal-title":"Immunity"},{"issue":"4","key":"11048_CR78","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2895","volume":"3","author":"M Nomura","year":"2020","unstructured":"Nomura M, Nagatomo R, Doi K, Shimizu J, Baba K, Saito T et al (2020) Association of short-chain fatty acids in the gut microbiome with clinical response to treatment with Nivolumab or Pembrolizumab in patients with solid cancer tumors. JAMA Netw Open 3(4):e202895. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2895","journal-title":"JAMA Netw Open"},{"issue":"19","key":"11048_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26196076","volume":"26","author":"XZ Wang","year":"2021","unstructured":"Wang XZ, Zhang P, Zhang X (2021) Probiotics regulate gut microbiota: an effective method to improve immunity. Molecules 26(19):6076. https:\/\/doi.org\/10.3390\/molecules26196076","journal-title":"Molecules"},{"issue":"1","key":"11048_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1868122","volume":"10","author":"Q Li","year":"2021","unstructured":"Li Q, Li Y, Wang Y, Xu L, Guo Y, Wang Y et al (2021) Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12. Oncoimmunology 10(1):1868122. https:\/\/doi.org\/10.1080\/2162402X.2020.1868122","journal-title":"Oncoimmunology"},{"issue":"9","key":"11048_CR81","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M et al (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16(9):563\u2013580. https:\/\/doi.org\/10.1038\/s41571-019-0218-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"11048_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0160-6","volume":"6","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chavez A, Keegan N, Khamashta MA et al (2020) Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers 6(1):38. https:\/\/doi.org\/10.1038\/s41572-020-0160-6","journal-title":"Nat Rev Dis Primers"},{"key":"11048_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01064","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Cong L, Jaber V, Lukiw WJ (2017) Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer\u2019s disease brain. Front Immunol 8:1064. https:\/\/doi.org\/10.3389\/fimmu.2017.01064","journal-title":"Front Immunol"},{"issue":"1","key":"11048_CR84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H (2021) Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol 18(1):4\u201317. https:\/\/doi.org\/10.1038\/s41423-020-00592-6","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"11048_CR85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrmicro2690","volume":"10","author":"PA Bron","year":"2011","unstructured":"Bron PA, van Baarlen P, Kleerebezem M (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10(1):66\u201378. https:\/\/doi.org\/10.1038\/nrmicro2690","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"11048_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A et al (2021) Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun 12(1):4077. https:\/\/doi.org\/10.1038\/s41467-021-24331-1","journal-title":"Nat Commun"},{"issue":"7756","key":"11048_CR87","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","volume":"569","author":"E Perez-Ruiz","year":"2019","unstructured":"Perez-Ruiz E, Minute L, Otano I, Alvarez M, Ochoa MC, Belsue V et al (2019) Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Nature 569(7756):428\u2013432. https:\/\/doi.org\/10.1038\/s41586-019-1162-y","journal-title":"Nature"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11048-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11048-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11048-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:51Z","timestamp":1787729451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11048-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":87,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["11048"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11048-0","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was sanctioned and overseen by the Animal Ethics Committee at the School of Life Sciences, Lanzhou University (No. EAF2024048). All applied methods were completed following the Committee\u2019s regulations\/guidelines.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}